441 related articles for article (PubMed ID: 11685275)
1. Aminolevulinic acid (Levulan) in photodynamic therapy of actinic keratoses.
Lang K; Schulte KW; Ruzicka T; Fritsch C
Skin Therapy Lett; 2001 Sep; 6(10):1-2, 5. PubMed ID: 11685275
[TBL] [Abstract][Full Text] [Related]
2. Topical photodynamic therapy: a new tool in cosmetic dermatology.
Touma DJ; Gilchrest BA
Semin Cutan Med Surg; 2003 Jun; 22(2):124-30. PubMed ID: 12877231
[TBL] [Abstract][Full Text] [Related]
3. Photodynamic therapy with aminolevulinic acid topical solution and visible blue light in the treatment of multiple actinic keratoses of the face and scalp: investigator-blinded, phase 3, multicenter trials.
Piacquadio DJ; Chen DM; Farber HF; Fowler JF; Glazer SD; Goodman JJ; Hruza LL; Jeffes EW; Ling MR; Phillips TJ; Rallis TM; Scher RK; Taylor CR; Weinstein GD
Arch Dermatol; 2004 Jan; 140(1):41-6. PubMed ID: 14732659
[TBL] [Abstract][Full Text] [Related]
4. Levulan: the first approved topical photosensitizer for the treatment of actinic keratosis.
Jeffes EW
J Dermatolog Treat; 2002; 13 Suppl 1():S19-23. PubMed ID: 12060513
[TBL] [Abstract][Full Text] [Related]
5. In vivo fluorescence kinetics and photodynamic therapy efficacy of delta-aminolevulinic acid-induced porphyrins in basal cell carcinomas and actinic keratoses; implications for optimization of photodynamic therapy.
Stefanidou M; Tosca A; Themelis G; Vazgiouraki E; Balas C
Eur J Dermatol; 2000; 10(5):351-6. PubMed ID: 10882942
[TBL] [Abstract][Full Text] [Related]
6. Development of a keratoacanthoma after topical photodynamic therapy with 5-aminolevulinic acid.
Maydan E; Nootheti PK; Goldman MP
J Drugs Dermatol; 2006 Sep; 5(8):804-6. PubMed ID: 16989196
[TBL] [Abstract][Full Text] [Related]
7. Randomized, double-blind, prospective study to compare topical 5-aminolaevulinic acid methylester with topical 5-aminolaevulinic acid photodynamic therapy for extensive scalp actinic keratosis.
Moloney FJ; Collins P
Br J Dermatol; 2007 Jul; 157(1):87-91. PubMed ID: 17501954
[TBL] [Abstract][Full Text] [Related]
8. Topical photodynamic therapy for dermatologic disorders: results and complications.
Redbord KP; Hanke CW
J Drugs Dermatol; 2007 Dec; 6(12):1197-202. PubMed ID: 18189059
[TBL] [Abstract][Full Text] [Related]
9. Photodynamic therapy of actinic keratoses with topical aminolevulinic acid hydrochloride and fluorescent blue light.
Jeffes EW; McCullough JL; Weinstein GD; Kaplan R; Glazer SD; Taylor JR
J Am Acad Dermatol; 2001 Jul; 45(1):96-104. PubMed ID: 11423841
[TBL] [Abstract][Full Text] [Related]
10. Treatment of actinic keratoses with sequential combination of 5-fluorouracil and photodynamic therapy.
Gilbert DJ
J Drugs Dermatol; 2005; 4(2):161-3. PubMed ID: 15776772
[TBL] [Abstract][Full Text] [Related]
11. Short incubation PDT versus 5-FU in treating actinic keratoses.
Smith S; Piacquadio D; Morhenn V; Atkin D; Fitzpatrick R
J Drugs Dermatol; 2003 Dec; 2(6):629-35. PubMed ID: 14711141
[TBL] [Abstract][Full Text] [Related]
12. Topical photodynamic therapy in the treatment of actinic keratoses and Bowen's disease in transplant recipients.
Dragieva G; Hafner J; Dummer R; Schmid-Grendelmeier P; Roos M; Prinz BM; Burg G; Binswanger U; Kempf W
Transplantation; 2004 Jan; 77(1):115-21. PubMed ID: 14724445
[TBL] [Abstract][Full Text] [Related]
13. Photodynamic therapy update 2007.
Gold MH
J Drugs Dermatol; 2007 Nov; 6(11):1131-7. PubMed ID: 18038501
[TBL] [Abstract][Full Text] [Related]
14. A multicenter, randomized, vehicle-controlled phase 2 study of blue light photodynamic therapy with aminolevulinic acid HCl 20% topical solution for the treatment of actinic keratoses on the upper extremities: the effect of occlusion during the drug incubation period.
Schmieder GJ; Huang EY; Jarratt M
J Drugs Dermatol; 2012 Dec; 11(12):1483-9. PubMed ID: 23377520
[TBL] [Abstract][Full Text] [Related]
15. A randomized, blinded, bilateral intraindividual, vehicle-controlled trial of the use of photodynamic therapy with 5-aminolevulinic acid and blue light for the treatment of actinic keratoses of the upper extremities.
Taub AF; Garretson CB
J Drugs Dermatol; 2011 Sep; 10(9):1049-56. PubMed ID: 22052276
[TBL] [Abstract][Full Text] [Related]
16. Treatment of facial actinic keratoses with aminolevulinic acid photodynamic therapy (ALA-PDT) or ingenol mebutate 0.015% gel with and without prior treatment with ALA-PDT.
Berman B; Nestor MS; Newburger J; Park H; Swenson N
J Drugs Dermatol; 2014 Nov; 13(11):1353-6. PubMed ID: 25607702
[TBL] [Abstract][Full Text] [Related]
17. Aminolevulinic acid photodynamic therapy for actinic keratoses/actinic cheilitis/acne: vascular lasers.
Alexiades-Armenakas M
Dermatol Clin; 2007 Jan; 25(1):25-33. PubMed ID: 17126739
[TBL] [Abstract][Full Text] [Related]
18. Large surface photodynamic therapy with aminolevulinic acid: treatment of actinic keratoses and beyond.
Bissonette R; Bergeron A; Liu Y
J Drugs Dermatol; 2004; 3(1 Suppl):S26-31. PubMed ID: 14964758
[TBL] [Abstract][Full Text] [Related]
19. Photodynamic therapy with low-strength ALA, repeated applications and short contact periods (40-60 minutes) in acne, photoaging and vitiligo.
Serrano G; Lorente M; Reyes M; Millán F; Lloret A; Melendez J; Navarro M; Navarro M
J Drugs Dermatol; 2009 Jun; 8(6):562-8. PubMed ID: 19537381
[TBL] [Abstract][Full Text] [Related]
20. Preferential relative porphyrin enrichment in solar keratoses upon topical application of delta-aminolevulinic acid methylester.
Fritsch C; Homey B; Stahl W; Lehmann P; Ruzicka T; Sies H
Photochem Photobiol; 1998 Aug; 68(2):218-21. PubMed ID: 9723214
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
